Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Graph

IONS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2015-05-31: Revenue $91.20M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IONS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$31.14MRoyalty$75.96MCollaborativeAgreement Revenue$133.14MCommercial$118.62MDAWNZERA Sales$26.56MOther Commercial$11.53MOther Royalties$6.04MResearch AndDevelopment Revenue$149.33MSpinraza Royalties$53.49MTryngolza$4.57MWainua JointDevelopment Revenue$16.19MWainus Royalties$16.44MRevenue$267.95MCost of revenue$2.74MOperating income-$102.29MOther income, net$987.00KSelling, general& administrative$150.40MPre-tax income-$113.38MIncome tax$1.26MNet income-$114.65M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IONS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Ionis Operations$267.95MRevenue$267.95MCost of revenue$2.74MOperating income-$102.29MOther income, net$987.00KSelling, general& administrative$150.40MPre-tax income-$113.38MIncome tax$1.26MNet income-$114.65M

Type Of Arrangement

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IONS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.BiogenCollaboration2018Neurology$15.00MBiogen Collaborations$133.87MGlaxo Smith KlineCollaboration$0.00Ono Collaboration$20.90MOtsuka Collaborations$9.39MRecordati AgCollaboration$21.08MRoche Collaborations$0.00Revenue$267.95MCost of revenue$2.74MOperating income-$102.29MOther income, net$987.00KSelling, general& administrative$150.40MPre-tax income-$113.38MIncome tax$1.26MNet income-$114.65M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endRevenue
2015-05-31$91.20M

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$267.95M$2.74M(m)$150.40M(m)$1.26M-$114.65M
2026-03-31$246.09M$2.98M(m)$150.36M(m)$218.00K-$92.53M
2025-12-31$203.33M$7.96M*(m)$130.19M*(m)$1.48M*-$229.39M
2025-09-30$156.72M$2.34M(m)$96.81M(m)$213.00K-$128.61M
2025-06-30$452.05M$4.15M(m)$90.62M(m)-$20.00K$123.55M
2025-03-31$131.61M$1.46M(m)$76.25M(m)$116.00K-$146.94M
2024-12-31$226.58M(m)(m)(m)(m)(m)-$104.35M
2024-09-30$133.81M$1.07M(m)$61.64M(m)-$3.62M-$140.48M
2024-06-30$225.25M$4.16M(m)$65.11M(m)$64.00K-$66.27M
2024-03-31$119.50M$2.15M(m)$52.64M(m)$75.00K-$142.80M
2023-12-31$324.50M(m)(m)(m)(m)(m)-$9.26M
2023-09-30$144.21M$2.19M(m)$69.95M(m)$6.60M-$147.41M
2023-06-30$188.41M$2.54M(m)$46.14M(m)$7.84M-$85.29M
2023-03-31$130.52M$1.34M(m)$45.52M(m)$11.38M-$124.32M
2022-12-31$151.89M(m)(m)(m)(m)(m)-$52.43M
2022-09-30$159.77M$1.51M(m)$34.42M(m)$283.00K-$46.99M
2022-06-30$133.79M$4.75M(m)$33.80M(m)$2.26M-$105.14M
2022-03-31$141.92M$4.17M(m)$34.13M(m)$1.09M-$65.17M
2021-12-31$440.01M(m)(m)(m)(m)(m)$224.61M
2021-09-30$133.09M$3.08M(m)$31.09M(m)-$1.31M-$82.47M
2021-06-30$125.75M$2.96M(m)$56.45M(m)$327.00K-$80.88M
2021-03-31$111.61M$2.58M(m)$61.20M(m)$130.00K-$89.87M
2020-12-31$290.28M(m)(m)(m)(m)(m)-$354.53M
2020-09-30$160.08M$3.09M(m)$68.45M(m)$5.06M-$24.47M
2020-06-30$145.54M$3.01M(m)$72.02M(m)$2.08M-$25.64M
2020-03-31$133.37M$2.55M(m)$74.99M(m)-$3.07M-$39.63M
2019-12-31$493.68M(m)(m)(m)(m)(m)$184.41M
2019-09-30$167.89M$967.00K(m)$60.04M(m)-$14.91M$26.16M
2019-06-30$163.81M$1.36M(m)$75.11M(m)-$6.93M-$876.00K
2019-03-31$297.21M$1.04M(m)$68.22M(m)$31.05M$84.44M
2018-12-31$192.11M(m)(m)(m)$181.33M(m)$320.08M
2018-09-30$145.40M$0.00(m)$68.71M$163.97M$452.00K-$4.56M
2018-06-30$117.75M$0.00(m)$66.20M$168.03M$358.00K-$40.36M
2018-03-31$144.42M$0.00(m)$43.65M$147.72M$15.00K-$1.42M
2017-12-31$167.79M(m)(m)(m)$173.99M(m)-$2.92M
2017-09-30$118.31M(m)(m)$26.79M$107.00M$961.00K-$2.61M
2017-06-30$112.27M(m)(m)$22.32M$105.82M$222.00K-$3.08M
2017-03-31$115.80M(m)(m)$13.68M$96.31M$0.00$8.96M
2016-12-31$160.35M(m)(m)(m)$119.19M(m)$25.86M
2016-09-30$110.93M(m)(m)$10.19M$94.82M$0.00$7.35M
2016-06-30$38.47M(m)(m)$9.82M$87.40M-$231.00K-$56.85M
2016-03-31$36.87M(m)(m)$10.56M$91.53M$232.00K-$62.92M
2015-12-31$51.57M(m)(m)(m)$114.51M(m)-$71.43M
2015-09-30$49.12M(m)(m)(m)$97.26M$0.00-$35.78M
2015-06-30$120.43M(m)(m)(m)$75.78M$789.00K$35.65M
2015-03-31$62.58M(m)(m)(m)$71.91M-$789.00K-$16.72M
2014-12-31$84.86M(m)(m)(m)$74.78M(m)$31.05M
2014-09-30$44.06M(m)(m)(m)$65.56M$1.40M-$26.68M
2014-06-30$57.08M(m)(m)(m)$63.73M$881.00K-$12.08M
2014-03-31$28.16M(m)(m)(m)$57.83M-$2.28M-$31.28M
2013-12-31$42.25M(m)(m)(m)$62.11M(m)(m)
2013-09-30$23.59M(m)$45.00M(m)$49.09M(m)(m)
2013-06-30$38.09M(m)$42.63M(m)$46.02M(m)(m)
2013-03-31$43.36M(m)$38.31M(m)$41.73M(m)(m)
2012-12-31$19.87M(m)(m)(m)$45.99M(m)(m)
2012-09-30$11.60M(m)$35.60M(m)$39.65M-$706.00K(m)
2012-06-30$47.34M(m)$40.44M(m)$43.64M(m)(m)
2012-03-31$23.23M(m)$38.71M(m)$41.69M$2.00K(m)
2011-12-31$32.40M(m)(m)(m)$51.02M(m)(m)
2011-09-30$20.71M(m)$39.92M(m)$43.03M(m)(m)
2011-06-30$24.82M(m)$36.01M(m)$38.88M$9.00K-$17.89M
2011-03-31$21.15M(m)$34.24M(m)$37.26M$2.00K-$19.99M
2010-12-31$26.42M(m)(m)(m)$42.28M(m)-$13.99M*
2010-09-30$28.62M(m)$34.72M(m)$37.57M(m)-$12.45M
2010-06-30$23.50M(m)$39.12M(m)$42.17M$2.00K-$25.15M
2010-03-31$29.93M(m)$31.99M(m)$34.81M(m)-$9.66M
2009-09-30$26.77M(m)$33.83M(m)$37.17M$724.00K-$11.58M
2009-06-30$30.99M(m)$32.15M(m)$35.82M-$11.00K-$2.73M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$514.04M$5.72M(m)$300.75M(m)$1.48M-$207.17M
2025-06-30$583.66M$5.61M(m)$166.87M(m)$96.00K-$23.39M
2024-06-30$344.75M$6.31M(m)$117.76M(m)$140.00K-$209.07M
2023-06-30$318.94M$3.88M(m)$91.66M(m)$19.22M-$209.61M
2022-06-30$275.71M$8.91M(m)$67.93M(m)$3.35M-$170.30M
2021-06-30$237.36M$5.54M(m)$117.65M(m)$457.00K-$170.74M
2020-06-30$278.90M$5.56M(m)$147.01M(m)-$988.00K-$65.26M
2019-06-30$461.03M$2.41M(m)$143.33M(m)$24.12M$83.57M
2018-06-30$262.17M$0.00(m)$109.85M$315.75M$372.00K-$41.77M
2017-06-30$228.07M(m)(m)$35.99M$202.14M$222.00K$5.88M
2016-06-30$75.34M(m)(m)$20.39M$178.92M$1.00K-$119.77M
2015-06-30$183.01M(m)(m)(m)$147.69M$0.00$18.93M
2014-06-30$85.24M(m)(m)(m)$121.55M-$1.40M-$43.36M
2013-06-30$81.45M(m)$80.94M(m)$87.75M(m)(m)
2012-06-30$70.58M(m)$79.15M(m)$85.33M$2.00K(m)
2011-06-30$45.97M(m)$70.25M(m)$76.14M$11.00K-$37.88M
2010-06-30$53.43M(m)$71.11M(m)$76.98M$2.00K-$34.81M
2009-06-30$62.57M(m)$60.69M(m)$68.04M$149.00K$183.49M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$740.38M$7.95M(m)$263.68M(m)$308.00K-$151.99M
2024-09-30$478.56M$7.38M(m)$179.40M(m)-$3.48M-$349.55M
2023-09-30$463.14M$6.07M(m)$161.61M(m)$25.82M-$357.02M
2022-09-30$435.48M$10.43M(m)$102.34M(m)$3.64M-$217.29M
2021-09-30$370.45M$8.62M(m)$148.75M(m)-$854.00K-$253.21M
2020-09-30$438.98M$8.65M(m)$215.46M(m)$4.08M-$89.73M
2019-09-30$628.92M$3.37M(m)$203.37M(m)$9.20M$109.73M
2018-09-30$407.56M$0.00(m)$178.56M$479.72M$824.00K-$46.34M
2017-09-30$346.39M(m)(m)$62.78M$309.14M$1.18M$3.27M
2016-09-30$186.27M(m)(m)$30.57M$273.74M$1.00K-$112.42M
2015-09-30$232.13M(m)(m)(m)$244.95M$0.00-$16.84M
2014-09-30$129.30M(m)(m)(m)$187.11M$2.00K-$70.04M
2013-09-30$105.04M(m)$122.80M(m)$136.84M(m)(m)
2012-09-30$82.18M(m)$113.40M(m)$124.98M-$704.00K(m)
2011-09-30$66.68M(m)$110.18M(m)$119.17M$11.00K(m)
2010-09-30$82.05M(m)$105.83M(m)$114.55M$2.00K-$47.27M
2009-09-30$89.34M(m)$94.52M(m)$105.20M$873.00K$171.91M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$943.71M$15.91M$915.62M$393.87M(m)$1.79M-$381.39M
2024-12-31$705.14M$11.21M$901.53M$267.47M(m)-$6.17M-$453.90M
2023-12-31$787.65M$9.13M$899.63M$232.62M(m)$32.32M-$366.29M
2022-12-31$587.37M$14.12M(m)$150.29M(m)$11.74M-$269.72M
2021-12-31$810.46M$10.84M$638.20M$186.35M(m)-$551.00K-$28.60M
2020-12-31$729.26M$11.95M$531.00M$354.32M(m)$345.19M-$444.26M
2019-12-31$1.12B$4.38M$461.50M$286.64M(m)$51.51M$278.14M
2018-12-31$599.67M$1.82M$411.90M$244.62M$661.05M-$291.14M$273.74M
2017-12-31$514.18M$0.00$372.50M$108.49M$483.13M-$5.98M$346.00K
2016-12-31$372.78M$0.00$340.40M$48.62M$392.94M$2.93M-$60.40M
2015-12-31$283.70M(m)$319.50M$37.17M$359.46M$372.00K-$88.28M
2014-12-31$214.16M(m)$238.90M(m)$261.89M-$15.41M-$38.98M
2013-12-31$147.28M(m)$173.70M(m)$198.95M-$5.91M-$60.64M
2012-12-31$102.05M(m)$154.60M(m)$170.97M-$9.11M(m)
2011-12-31$99.09M(m)$153.10M(m)$170.19M$11.00K(m)
2010-12-31$108.47M(m)$145.16M(m)$156.83M$92.00K-$61.25M
2009-12-31$121.60M(m)$134.62M(m)$149.14M$3.19M$155.07M
2008-12-31$107.19M(m)$106.44M(m)$120.25M(m)-$18.17M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10